HCV screen-and-treat programs are feasible in Malaysian drug rehabilitation centres but face challenges in linkage to confirmatory testing and treatment initiation, largely due to limitations imposed by the duration of stay. While DAA therapy is highly effective when completed, strategies addressing diagnostic streamlining, potentially shorter regimens, and continuity of care post-release are crucial to optimise HCV elimination efforts in this vulnerable population.
Kaman et al. (Thu,) studied this question.